ABT
NYSE Abbott Laboratories$101.19 ↑ +0.24 (+0.24%) Trading Up from the previous close of $100.95
- YTD change
- -19.24%
- vs 20-day SMA
- -2.67%
- vs 200-day SMA
- -3.11%
Price ranges
Price & Performance
-0.93 (-0.91%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 29.0% away from all-time highs of $142.60
- ABT is down 19% since the beginning of the year
- ABT is down 24% over the past 12 months
- ABT is down 8% over the past 1 month
- 1% of all ABT investors are betting against ABT
- Number of investors short ABT has gone down 12% versus last month
ABT reads not so good: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -24.6%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- -2.41%
- vs 8-day SMA
- -0.92%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
